Gulfo Adele M. — SEC insider filings

SEC reporting owner CIK 1647102. 43 insider filings on record with FilingPulse; latest filed 2026-09-17.

Transaction summary — filings shown

Covers all 43 filings on record, filed 2020-09-17 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Enpro Inc. (NPO)Director35——41
Myovant Sciences Ltd. (MYOV)Director4——7
NewAmsterdam Pharma Co N.V. (NAMS)Director2——4
Tyra Biosciences, Inc. (TYRA)Director2——2

Insider filings — Gulfo Adele M.

FiledFormIssuerReported transactionsSource
2026-09-174Enpro Inc. (NPO)Grant/award (A): 5 (derivative) @ $287.16 · Grant/award (A): 0.57 (derivative) @ $287.16EDGAR
2026-06-184Enpro Inc. (NPO)Grant/award (A): 4 (derivative) @ $363.62 · Grant/award (A): 0.45 (derivative) @ $363.62EDGAR
2026-06-014Tyra Biosciences, Inc. (TYRA)Grant/award (A): 13,160 (derivative) @ $0EDGAR
2026-03-194Enpro Inc. (NPO)Grant/award (A): 5 (derivative) @ $250.59 · Grant/award (A): 0.66 (derivative) @ $250.59EDGAR
2026-02-124Enpro Inc. (NPO)Grant/award (A): 567 @ $246.91EDGAR
2026-01-094NewAmsterdam Pharma Co N.V. (NAMS)Grant/award (A): 3,400 · Grant/award (A): 15,300 (derivative) @ $0EDGAR
2026-01-054Enpro Inc. (NPO)Grant/award (A): 116.75 (derivative) @ $214.13EDGAR
2025-12-184Enpro Inc. (NPO)Grant/award (A): 6 (derivative) @ $205.19 · Grant/award (A): 0.60 (derivative) @ $205.19EDGAR
2025-10-014Enpro Inc. (NPO)Grant/award (A): 110.62 (derivative) @ $226EDGAR
2025-09-184Enpro Inc. (NPO)Grant/award (A): 6 (derivative) @ $217.89 · Grant/award (A): 0.41 (derivative) @ $217.89EDGAR
2025-07-014Enpro Inc. (NPO)Grant/award (A): 130.51 (derivative) @ $191.55EDGAR
2025-06-204Enpro Inc. (NPO)Grant/award (A): 7 (derivative) @ $185.86 · Grant/award (A): 0.26 (derivative) @ $185.86EDGAR
2025-04-174NewAmsterdam Pharma Co N.V. (NAMS)Grant/award (A): 10,860 · Grant/award (A): 50,700 (derivative) @ $0EDGAR
2025-04-014Enpro Inc. (NPO)Grant/award (A): 154.52 (derivative) @ $161.79EDGAR
2025-03-204Enpro Inc. (NPO)Grant/award (A): 7 (derivative) @ $175.76EDGAR
2025-02-134Enpro Inc. (NPO)Grant/award (A): 685 (derivative) @ $182.27EDGAR
2025-01-314Tyra Biosciences, Inc. (TYRA)Grant/award (A): 37,200 (derivative) @ $0EDGAR
2024-12-194Enpro Inc. (NPO)Grant/award (A): 7 (derivative) @ $175.86EDGAR
2024-09-194Enpro Inc. (NPO)Grant/award (A): 8 (derivative) @ $156.77EDGAR
2024-06-244Enpro Inc. (NPO)Grant/award (A): 8 (derivative) @ $146.91EDGAR
2024-03-214Enpro Inc. (NPO)Grant/award (A): 8 (derivative) @ $159.77EDGAR
2024-02-154Enpro Inc. (NPO)Grant/award (A): 803 @ $155.66EDGAR
2023-12-144Enpro Inc. (NPO)Grant/award (A): 8 (derivative) @ $140.49EDGAR
2023-09-144ENPRO INDUSTRIES, INC (NPO)Grant/award (A): 9 (derivative) @ $123.90EDGAR
2023-06-154ENPRO INDUSTRIES, INC (NPO)Grant/award (A): 9 (derivative) @ $125.72EDGAR
2023-03-164ENPRO INDUSTRIES, INC (NPO)Grant/award (A): 12 (derivative) @ $95.94EDGAR
2023-03-104Myovant Sciences Ltd. (MYOV)Disposition to issuer (D): 3,673 · Disposition to issuer (D): 45,000 (derivative) · Disposition to issuer (D): 21,603 (derivative) · Disposition to issuer (D): 21,096 (derivative)EDGAR
2023-02-174ENPRO INDUSTRIES, INC (NPO)Grant/award (A): 942 @ $116.69EDGAR
2022-12-154ENPRO INDUSTRIES, INC (NPO)Grant/award (A): 10 (derivative) @ $107.94EDGAR
2022-10-284Myovant Sciences Ltd. (MYOV)Grant/award (A): 9,859 @ $0EDGAR
2022-09-154ENPRO INDUSTRIES, INC (NPO)Grant/award (A): 12 (derivative) @ $90.25EDGAR
2022-06-164ENPRO INDUSTRIES, INC (NPO)Grant/award (A): 13 (derivative) @ $87.50EDGAR
2022-03-174ENPRO INDUSTRIES, INC (NPO)Grant/award (A): 10 (derivative) @ $106.51EDGAR
2022-02-164ENPRO INDUSTRIES, INC (NPO)Grant/award (A): 1,041 @ $105.64EDGAR
2021-12-164ENPRO INDUSTRIES, INC (NPO)Grant/award (A): 10 (derivative) @ $106.21EDGAR
2021-11-094Myovant Sciences Ltd. (MYOV)Grant/award (A): 21,096 (derivative) @ $0EDGAR
2021-09-174ENPRO INDUSTRIES, INC (NPO)Grant/award (A): 13 (derivative) @ $82.96EDGAR
2021-06-174ENPRO INDUSTRIES, INC (NPO)Grant/award (A): 11 (derivative) @ $98.35EDGAR
2021-03-184ENPRO INDUSTRIES, INC (NPO)Grant/award (A): 11 (derivative) @ $91.41EDGAR
2021-02-184ENPRO INDUSTRIES, INC (NPO)Grant/award (A): 1,432 @ $76.82EDGAR
2020-12-184ENPRO INDUSTRIES, INC (NPO)Grant/award (A): 14 (derivative) @ $73.91EDGAR
2020-09-184ENPRO INDUSTRIES, INC (NPO)Grant/award (A): 17 (derivative) @ $57.46EDGAR
2020-09-174Myovant Sciences Ltd. (MYOV)Grant/award (A): 21,603 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1647102 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs